Advertisement

Trends in Death Rate 2009 to 2018 Following Percutaneous Coronary Intervention Stratified by Acuteness of Presentation

      Percutaneous coronary intervention (PCI) has evolved dramatically, along with patient complexity. We studied trends in in-hospital mortality with changes in patient complexity over the last decade stratified by clinical presentation. The study population included all patients presenting to the cardiac catheterization lab between January 2009 and July 2018. Expected in-hospital mortality was calculated using the National Cardiovascular Data Registry CathPCI risk scoring system. Yearly mean in-hospital mortality rates (%) were plotted and smoothed by weighted least squares regression for each presentation: ST-elevation myocardial infarction (STEMI), non–ST-elevation acute coronary syndrome (NSTE-ACS), and stable ischemic coronary artery disease (SI CAD). The overall cohort included 13,732 patients who underwent PCI during the study period, of whom 2,142 were for STEMI, 2,836 for NSTE-ACS, and 8,754 for SI CAD. Indications for PCI have changed over time, with more PCIs being performed for NSTE-ACS and STEMI than for SI CAD. NSTE-ACS and STEMI patients had a steady decrease in in-hospital mortality over time compared with SI CAD patients. Overall observed mortality continues to decrease in NSTE-ACS patients, with reduction in the observed mortality rate within the STEMI population to below expected since 2013. Patient complexity has not changed significantly. These results may be attributed to improved patient selection coupled with optimal pharmacotherapy with more robust therapies during procedure and hospitalization.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Benjamin EJ
        • Virani SS
        • Callaway CW
        • Chamberlain AM
        • Chang AR
        • Cheng S
        • Chiuve SE
        • Cushman M
        • Delling FN
        • Deo R
        • de Ferranti SD
        • Ferguson JF
        • Fornage M
        • Gillespie C
        • Isasi CR
        • Jimenez MC
        • Jordan LC
        • Judd SE
        • Lackland D
        • Lichtman JH
        • Lisabeth L
        • Liu S
        • Longenecker CT
        • Lutsey PL
        • Mackey JS
        • Matchar DB
        • Matsushita K
        • Mussolino ME
        • Nasir K
        • O'Flaherty M
        • Palaniappan LP
        • Pandey A
        • Pandey DK
        • Reeves MJ
        • Ritchey MD
        • Rodriguez CJ
        • Roth GA
        • Rosamond WD
        • Sampson UKA
        • Satou GM
        • Shah SH
        • Spartano NL
        • Tirschwell DL
        • Tsao CW
        • Voeks JH
        • Willey JZ
        • Wilkins JT
        • Wu JH
        • Alger HM
        • Wong SS
        • Muntner P
        • American Heart Association Council on Epidemiology, Prevention Statistics Committee, Stroke Statistics Subcommittee
        Heart disease and stroke statistics-2018 update: a report from the American Heart Association.
        Circulation. 2018; 137: e67-e492
        • Bonello L
        • Laine M
        • Puymirat E
        • Lemesle G
        • Thuny F
        • Paganelli F
        • Michelet P
        • Roch A
        • Kerbaul F
        • Boyer L
        Timing of coronary invasive strategy in non-ST-segment elevation acute coronary syndromes and clinical outcomes: an updated meta-analysis.
        JACC Cardiovasc Interv. 2016; 9: 2267-2276
        • Keeley EC
        • Boura JA
        • Grines CL
        Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.
        Lancet. 2003; 361: 13-20
        • James SK
        • Stenestrand U
        • Lindback J
        • Carlsson J
        • Schersten F
        • Nilsson T
        • Wallentin L
        • Lagerqvist B
        • SCAAR Study Group
        Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden.
        N Engl J Med. 2009; 360: 1933-1945
        • Hamm CW
        • Bassand JP
        • Agewall S
        • Bax J
        • Boersma E
        • Bueno H
        • Caso P
        • Dudek D
        • Gielen S
        • Huber K
        • Ohman M
        • Petrie MC
        • Sonntag F
        • Uva MS
        • Storey RF
        • Wijns W
        • Zahger D
        • ESC Committee for Practice Guidelines
        ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC).
        Eur Heart J. 2011; 32: 2999-3054
        • Fokkema ML
        • James SK
        • Albertsson P
        • Akerblom A
        • Calais F
        • Eriksson P
        • Jensen J
        • Nilsson T
        • de Smet BJ
        • Sjogren I
        • Thorvinger B
        • Lagerqvist B
        Population trends in percutaneous coronary intervention: 20-year results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry).
        J Am Coll Cardiol. 2013; 61: 1222-1230
        • Cutlip DE
        • Windecker S
        • Mehran R
        • Boam A
        • Cohen DJ
        • van Es GA
        • Steg PG
        • Morel MA
        • Mauri L
        • Vranckx P
        • McFadden E
        • Lansky A
        • Hamon M
        • Krucoff MW
        • Serruys PW
        • Academic Research Consortium
        Clinical end points in coronary stent trials: a case for standardized definitions.
        Circulation. 2007; 115: 2344-2351
        • Peterson ED
        • Dai D
        • DeLong ER
        • Brennan JM
        • Singh M
        • Rao SV
        • Shaw RE
        • Roe MT
        • Ho KK
        • Klein LW
        • Krone RJ
        • Weintraub WS
        • Brindis RG
        • Rumsfeld JS
        • Spertus JA
        • Participants NR
        Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry.
        J Am Coll Cardiol. 2010; 55: 1923-1932
        • Brennan JM
        • Curtis JP
        • Dai D
        • Fitzgerald S
        • Khandelwal AK
        • Spertus JA
        • Rao SV
        • Singh M
        • Shaw RE
        • Ho KK
        • Krone RJ
        • Weintraub WS
        • Weaver WD
        • Peterson ED
        • National Cardiovascular Data Registry
        Enhanced mortality risk prediction with a focus on high-risk percutaneous coronary intervention: results from 1,208,137 procedures in the NCDR (National Cardiovascular Data Registry).
        JACC Cardiovasc Interv. 2013; 6: 790-799
        • Weintraub WS
        • Spertus JA
        • Kolm P
        • Maron DJ
        • Zhang Z
        • Jurkovitz C
        • Zhang W
        • Hartigan PM
        • Lewis C
        • Veledar E
        • Bowen J
        • Dunbar SB
        • Deaton C
        • Kaufman S
        • O'Rourke RA
        • Goeree R
        • Barnett PG
        • Teo KK
        • Boden WE
        • Group CTR
        • Mancini GB
        Effect of PCI on quality of life in patients with stable coronary disease.
        N Engl J Med. 2008; 359: 677-687
        • Boden WE
        • O'Rourke RA
        • Teo KK
        • Hartigan PM
        • Maron DJ
        • Kostuk WJ
        • Knudtson M
        • Dada M
        • Casperson P
        • Harris CL
        • Chaitman BR
        • Shaw L
        • Gosselin G
        • Nawaz S
        • Title LM
        • Gau G
        • Blaustein AS
        • Booth DC
        • Bates ER
        • Spertus JA
        • Berman DS
        • Mancini GB
        • Weintraub WS
        • COURAGE Trial Research Group
        Optimal medical therapy with or without PCI for stable coronary disease.
        N Engl J Med. 2007; 356: 1503-1516
        • Iantorno M
        • Weintraub WS
        Cost-effectiveness and economic burden of PCI.
        Cardiovasc Revasc Med. 2018; 19: 561-563
        • Group BDS
        • Frye RL
        • August P
        • Brooks MM
        • Hardison RM
        • Kelsey SF
        • MacGregor JM
        • Orchard TJ
        • Chaitman BR
        • Genuth SM
        • Goldberg SH
        • Hlatky MA
        • Jones TL
        • Molitch ME
        • Nesto RW
        • Sako EY
        • Sobel BE
        A randomized trial of therapies for type 2 diabetes and coronary artery disease.
        N Engl J Med. 2009; 360: 2503-2515
        • Mancini GB
        • Bates ER
        • Maron DJ
        • Hartigan P
        • Dada M
        • Gosselin G
        • Kostuk W
        • Sedlis SP
        • Shaw LJ
        • Berman DS
        • Berger PB
        • Spertus J
        • Mavromatis K
        • Knudtson M
        • Chaitman BR
        • O'Rourke RA
        • Weintraub WS
        • Teo K
        • Boden WE
        • COURAGE Trial Investigators and Coordinators
        Quantitative results of baseline angiography and percutaneous coronary intervention in the COURAGE trial.
        Circ Cardiovasc Qual Outcomes. 2009; 2: 320-327
        • Fihn SD
        • Blankenship JC
        • Alexander KP
        • Bittl JA
        • Byrne JG
        • Fletcher BJ
        • Fonarow GC
        • Lange RA
        • Levine GN
        • Maddox TM
        • Naidu SS
        • Ohman EM
        • Smith PK
        2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
        J Am Coll Cardiol. 2014; 64: 1929-1949
        • Patel MR
        • Calhoon JH
        • Dehmer GJ
        • Grantham JA
        • Maddox TM
        • Maron DJ
        • Smith PK
        ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 appropriate use criteria for coronary revascularization in patients with stable ischemic heart disease: a report of the American College of Cardiology appropriate use criteria task force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons.
        J Am Coll Cardiol. 2017; 69: 2212-2241
        • Nakazawa G
        • Finn AV
        • Joner M
        • Ladich E
        • Kutys R
        • Mont EK
        • Gold HK
        • Burke AP
        • Kolodgie FD
        • Virmani R
        Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study.
        Circulation. 2008; 118: 1138-1145
        • De Luca G
        • Dirksen MT
        • Spaulding C
        • Kelbaek H
        • Schalij M
        • Thuesen L
        • van der Hoeven B
        • Vink MA
        • Kaiser C
        • Musto C
        • Chechi T
        • Spaziani G
        • Diaz de la Llera LS
        • Pasceri V
        • Di Lorenzo E
        • Violini R
        • Cortese G
        • Suryapranata H
        • Stone GW
        • Drug-Eluting Stent in Primary Angioplasty (DESERT) Cooperation
        Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials.
        Arch Intern Med. 2012; 172 (discussion 621–622): 611-621
        • Bangalore S
        • Amoroso N
        • Fusaro M
        • Kumar S
        • Feit F
        Outcomes with various drug-eluting or bare metal stents in patients with ST-segment-elevation myocardial infarction: a mixed treatment comparison analysis of trial level data from 34 068 patient-years of follow-up from randomized trials.
        Circ Cardiovasc Interv. 2013; 6: 378-390
        • Jeger RV
        • Radovanovic D
        • Hunziker PR
        • Pfisterer ME
        • Stauffer JC
        • Erne P
        • Urban P
        • AMIS Plus Registry Investigators
        Ten-year trends in the incidence and treatment of cardiogenic shock.
        Ann Intern Med. 2008; 149: 618-626
        • Babaev A
        • Frederick PD
        • Pasta DJ
        • Every N
        • Sichrovsky T
        • Hochman JS
        • NRMI Investigators
        Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock.
        JAMA. 2005; 294: 448-454
        • Hochman JS
        • Sleeper LA
        • Webb JG
        • Sanborn TA
        • White HD
        • Talley JD
        • Buller CE
        • Jacobs AK
        • Slater JN
        • Col J
        • McKinlay SM
        • LeJemtel TH
        Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock.
        N Engl J Med. 1999; 341: 625-634
        • Hochman JS
        Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm.
        Circulation. 2003; 107: 2998-3002
        • Prondzinsky R
        • Lemm H
        • Swyter M
        • Wegener N
        • Unverzagt S
        • Carter JM
        • Russ M
        • Schlitt A
        • Buerke U
        • Christoph A
        • Schmidt H
        • Winkler M
        • Thiery J
        • Werdan K
        • Buerke M
        Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome.
        Crit Care Med. 2010; 38: 152-160
        • Thiele H
        • Zeymer U
        • Neumann FJ
        • Ferenc M
        • Olbrich HG
        • Hausleiter J
        • Richardt G
        • Hennersdorf M
        • Empen K
        • Fuernau G
        • Desch S
        • Eitel I
        • Hambrecht R
        • Fuhrmann J
        • Bohm M
        • Ebelt H
        • Schneider S
        • Schuler G
        • Werdan K
        • IABP-SHOCK II Trial Investigators
        Intraaortic balloon support for myocardial infarction with cardiogenic shock.
        N Engl J Med. 2012; 367: 1287-1296
        • O'Neill WW
        • Grines C
        • Schreiber T
        • Moses J
        • Maini B
        • Dixon SR
        • Ohman EM
        Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device.
        Am Heart J. 2018; 202: 33-38
        • Reynolds HR
        • Hochman JS
        Cardiogenic shock: current concepts and improving outcomes.
        Circulation. 2008; 117: 686-697
        • Mozaffarian D
        • Benjamin EJ
        • Go AS
        • Arnett DK
        • Blaha MJ
        • Cushman M
        • de Ferranti S
        • Despres JP
        • Fullerton HJ
        • Howard VJ
        • Huffman MD
        • Judd SE
        • Kissela BM
        • Lackland DT
        • Lichtman JH
        • Lisabeth LD
        • Liu S
        • Mackey RH
        • Matchar DB
        • McGuire DK
        • Mohler 3rd, ER
        • Moy CS
        • Muntner P
        • Mussolino ME
        • Nasir K
        • Neumar RW
        • Nichol G
        • Palaniappan L
        • Pandey DK
        • Reeves MJ
        • Rodriguez CJ
        • Sorlie PD
        • Stein J
        • Towfighi A
        • Turan TN
        • Virani SS
        • Willey JZ
        • Woo D
        • Yeh RW
        • Turner MB
        • American Heart Association Statistics Committee, Stroke Statistics Subcommittee
        Heart disease and stroke statistics—2015 update: a report from the American Heart Association.
        Circulation. 2015; 131: e29-e322
        • Geri G
        • Dumas F
        • Bougouin W
        • Varenne O
        • Daviaud F
        • Pene F
        • Lamhaut L
        • Chiche JD
        • Spaulding C
        • Mira JP
        • Empana JP
        • Cariou A
        Immediate percutaneous coronary intervention is associated with improved short- and long-term survival after out-of-hospital cardiac arrest.
        Circ Cardiovasc Interv. 2015; 8e002303
        • Callaway CW
        • Donnino MW
        • Fink EL
        • Geocadin RG
        • Golan E
        • Kern KB
        • Leary M
        • Meurer WJ
        • Peberdy MA
        • Thompson TM
        • Zimmerman JL
        Part 8: post-cardiac arrest care: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care.
        Circulation. 2015; 132: S465-S482
        • Jeong J
        • Ro YS
        • Shin SD
        • Song KJ
        • Hong KJ
        • Ahn KO
        Association of time from arrest to percutaneous coronary intervention with survival outcomes after out-of-hospital cardiac arrest.
        Resuscitation. 2017; 115: 148-154
        • Patel N
        • Patel NJ
        • Macon CJ
        • Thakkar B
        • Desai M
        • Rengifo-Moreno P
        • Alfonso CE
        • Myerburg RJ
        • Bhatt DL
        • Cohen MG
        Trends and outcomes of coronary angiography and percutaneous coronary intervention after out-of-hospital cardiac arrest associated with ventricular fibrillation or pulseless ventricular tachycardia.
        JAMA Cardiol. 2016; 1: 890-899